|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
Á¦ ¸ñ |
IHQzLBubMmSm |
|
ÀÌ ¸§ |
Carlos |
³¯ Â¥ |
2018/06/29 |
Á¶ ȸ |
1 |
|
What line of work are you in? north-discounted.com review
Merck in April replaced its long-time research chief, Peter Kim, with Roger Perlmutter, a former Amgen Inc research head who is expected to better acquaint Merck with biotech drugs - injectable drugs made in living cells that have become standard treatments for a wide array of diseases, including cancer and rheumatoid arthritis.
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|